Global Cell and Gene Therapy Company Miltenyi Biotec is Expanding its Operations in Maryland 

BALTIMORE, MD (March 15, 2022) — Global biotechnology business Miltenyi Biotec is expanding its operations in Maryland and transferring its North American headquarters to Gaithersburg. The company is working on expanding its 1201 Clopper Road facility to support additional manufacturing, research and development, quality assurance, and more. Miltenyi Biotec plans to add 130 new full-time jobs in Maryland, giving it a total of 300 employees in the state by the end of the year.

“By selecting Maryland for its North American headquarters, Miltenyi Biotec will help us continue growing our industry and further our efforts in remaining one of the top 10 life sciences clusters in the nation,” said Governor Larry Hogan. “We welcome the company’s continued investment in Montgomery County and look forward to supporting their efforts in Maryland and across the globe.”

This is not the company’s first investment in Maryland in recent years. In 2014, Miltenyi Biotec acquired Gaithersburg’s lentiviral vector manufacturing company Lentigen Technology Inc., which develops and commercializes therapeutics for stem cell therapies and oncology. In 2017, the company acquired Living Pharma, Inc., a startup of the University of Maryland, Baltimore that develops personalized cell therapy for targeted individuals’ cancers and diseases. Both became part of Miltenyi Biotec’s CDMO business unit with locations in Gaithersburg, Md. and San Jose, Calif. 

To assist with job creation, the company has submitted a notice of intent to utilize the state’s More Jobs for Marylanders program and Job Creation Tax Credit, both managed by the Maryland Department of Commerce. There are currently more than three dozen job openings posted on the Miltenyi Biotec website related to its headquarters, distribution, R&D, and CDMO operations in Gaithersburg.

“Miltenyi Biotec’s decision to make Maryland its North American home is a testament to the strength of our life sciences industry as well as the supportive business climate we’ve established in our state,” said Maryland Commerce Secretary Mike Gill. “We’re thrilled the company has chosen to expand and create more good jobs in Maryland.”

Read the full article at: commerce.maryland.gov

Co Authors :